Efficacy and Safety of Anlotinib Combined with PD-1 Blockades for Patients with Previously Treated Epithelial Ovarian Cancer: A Retrospective Study

PURPOSE: This study was to investigate the efficacy and safety of anlotinib combined with programmed cell death protein 1 (PD-1) blockades for patients with previously treated advanced epithelial ovarian cancer (EOC). PATIENTS AND METHODS: Present study was designed as a retrospective study, a total...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiao-Yuan, Rao, Yang, Sun, Bing, Mao, Xue-Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013415/
https://www.ncbi.nlm.nih.gov/pubmed/35440872
http://dx.doi.org/10.2147/IJGM.S352536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013415/
https://www.ncbi.nlm.nih.gov/pubmed/35440872
http://dx.doi.org/10.2147/IJGM.S352536

Ejemplares similares